ONCO vs NIVF
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 02, 2026
ONCO
NIVF
Investment Advisor Scores
NIVF
AI Analyst Insights
Detailed Metrics Comparison
| Metric | ONCO | NIVF | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 0.0015 | Tie |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -83.9% | -4.7% | NIVF |
| Earnings Growth | 0.0% | 0.0% | Tie |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 47.3/100 | 26.9/100 | ONCO |
| Profit Margin | 0.0% | 24.2% | NIVF |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | BUY | AVOID NEW MONEY | ONCO |
Relative Price Performance (Last 90 Days)
Current Technical Phase
ONCO
MarkupPrice above SMA50, rising 50-day trend (28.3% over 20 days), RSI 63
NIVF
NeutralMixed signals - no dominant trend phase, RSI 41
Fundamentals Snapshot
| Metric | ONCO | NIVF |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 0.0 | 0.0 |
| Trailing P/E | 0.0 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.8% | 0.0% |
| Gross Margin | 0.8% | 0.2% |
| Operating Margin | -11.9% | -1.8% |
| EPS | 3103.90 | -34064.71 |
| Dividend Yield | — | — |